Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CUA 2022 Annual Meeting Abstracts - Podium Session 1: BPH, GU Trauma and Reconstruction, Neurogenic Bladder, Urinary Incontinence and Voiding Dysfunction, Pediatrics Friday, June 24, 2022 • 13:30-14:30.

Literature DB >> 35667349

CUA 2022 Annual Meeting Abstracts - Podium Session 1: BPH, GU Trauma and Reconstruction, Neurogenic Bladder, Urinary Incontinence and Voiding Dysfunction, Pediatrics Friday, June 24, 2022 • 13:30-14:30.

Abstract

Entities: Chemical

Year: 2022 PMID： 35667349 PMCID： PMC9239717 DOI： 10.5489/cuaj.7919

Source DB: PubMed Journal: Can Urol Assoc J ISSN： 1911-6470 Impact factor: 2.052

Keyword Cloud
References

× No keyword cloud information.

11 in total

Review 1. Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials.

Authors: Youcheng Lin; Xun Wu; Abai Xu; Rui Ren; Xueqiong Zhou; Yong Wen; Yong Zou; Mancheng Gong; Chunxiao Liu; Zexuan Su; Thomas R W Herrmann
Journal: World J Urol Date: 2015-12-23 Impact factor: 4.226

2. Another Therapeutic Role for Intravesical Botulinum Toxin: Patients with Long-stay Catheters and Refractory Bladder Pain and Catheter Bypass Leakage.

Authors: Matthew J Young; Nadir I Osman; Laura Phillips; Altaf Mangera; Sheilagh V Reid; Richard D Inman; Christopher R Chapple
Journal: Eur Urol Focus Date: 2018-11-02

3. Successful treatment with intradetrusor Botulinum-A toxin for urethral urinary leakage (catheter bypassing) in patients with end-staged multiple sclerosis and indwelling suprapubic catheters.

Authors: Elvira Lekka; Ling K Lee
Journal: Eur Urol Date: 2006-01-06 Impact factor: 20.096

4. WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation^® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia.

Authors: Peter Gilling; Neil Barber; Mohamed Bidair; Paul Anderson; Mark Sutton; Tev Aho; Eugene Kramolowsky; Andrew Thomas; Barrett Cowan; Ronald P Kaufman; Andrew Trainer; Andrew Arther; Gopal Badlani; Mark Plante; Mihir Desai; Leo Doumanian; Alexis E Te; Mark DeGuenther; Claus Roehrborn
Journal: J Urol Date: 2018-01-31 Impact factor: 7.450

5. Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results.

Authors: Kevin C Zorn; Mohamed Bidair; Andrew Trainer; Andrew Arther; Eugene Kramolowsky; Mihir Desai; Leo Doumanian; Dean Elterman; Ronald P Kaufman; James Lingeman; Amy Krambeck; Gregg Eure; Gopal Badlani; Mark Plante; Edward Uchio; Greg Gin; S Larry Goldenberg; Ryan Paterson; Alan So; Mitchell Humphreys; Claus Roehrborn; Steven Kaplan; Jay Motola; Naeem Bhojani
Journal: BJUI Compass Date: 2021-10-28

6. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019.

Authors: Harris E Foster; Philipp Dahm; Tobias S Kohler; Lori B Lerner; J Kellogg Parsons; Timothy J Wilt; Kevin T McVary
Journal: J Urol Date: 2019-08-08 Impact factor: 7.450

7. Living with an indwelling urethral catheter in a community setting: Exploring triggers for unscheduled community nurse "out-of-hours" visits.

Authors: William G Mackay; Teresa MacIntosh; Angela Kydd; Anne Fleming; Cate O'Kane; Ashley Shepherd; Suzanne Hagen; Craig Williams; Janice Mundie; Carol Russell; Fiona Rodgers; Margaret MacLachlan; Rhona Galbraith; Jean Rankin; Val McIver
Journal: J Clin Nurs Date: 2017-12-27 Impact factor: 3.036

8. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial.

Authors: Rainer M Kuntz; Karin Lehrich; Sascha A Ahyai
Journal: Eur Urol Date: 2007-08-28 Impact factor: 20.096

9. Comparison of < 100 cc prostates and > 100 cc prostates undergoing aquablation for benign prostatic hyperplasia.

Authors: N Bhojani; D-D Nguyen; R P Kaufman; D Elterman; K C Zorn
Journal: World J Urol Date: 2018-10-28 Impact factor: 4.226